- Home
- PNW vs QGEN Comparison
PNW vs QGEN Comparison
Compare PNW & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNW
- QGEN
- Stock Information
- Founded
- PNW 1985
- QGEN 1986
- Country
- PNW United States
- QGEN Netherlands
- Employees
- PNW N/A
- QGEN N/A
- Industry
- PNW Electric Utilities: Central
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- PNW Utilities
- QGEN Health Care
- Exchange
- PNW Nasdaq
- QGEN Nasdaq
- Market Cap
- PNW 9.7B
- QGEN 9.5B
- IPO Year
- PNW N/A
- QGEN 1996
- Fundamental
- Price
- PNW $85.61
- QGEN $45.06
- Analyst Decision
- PNW Buy
- QGEN Buy
- Analyst Count
- PNW 13
- QGEN 8
- Target Price
- PNW $84.50
- QGEN $52.29
- AVG Volume (30 Days)
- PNW 1.1M
- QGEN 824.8K
- Earning Date
- PNW 11-06-2024
- QGEN 02-04-2025
- Dividend Yield
- PNW 4.18%
- QGEN 2.93%
- EPS Growth
- PNW 27.39
- QGEN N/A
- EPS
- PNW 5.34
- QGEN 0.41
- Revenue
- PNW $5,021,081,000.00
- QGEN $1,966,174,000.00
- Revenue This Year
- PNW $6.05
- QGEN $2.73
- Revenue Next Year
- PNW $2.71
- QGEN $5.55
- P/E Ratio
- PNW $16.02
- QGEN $108.68
- Revenue Growth
- PNW 6.52
- QGEN 0.62
- 52 Week Low
- PNW $65.20
- QGEN $39.03
- 52 Week High
- PNW $95.42
- QGEN $47.44
- Technical
- Relative Strength Index (RSI)
- PNW 36.09
- QGEN 57.54
- Support Level
- PNW $83.97
- QGEN $43.78
- Resistance Level
- PNW $93.23
- QGEN $45.20
- Average True Range (ATR)
- PNW 1.61
- QGEN 0.74
- MACD
- PNW -0.58
- QGEN -0.03
- Stochastic Oscillator
- PNW 17.71
- QGEN 52.38
About PNW Pinnacle West Capital Corporation
Pinnacle West is a holding company whose principal subsidiary is Arizona Public Service, a vertically integrated electric utility that serves 1.4 million customers across a 35,000-square-mile territory in central Arizona, including Phoenix. APS owns or leases more than 6 gigawatts of power generation capacity, including a 29% ownership stake in one of the largest nuclear plants in the US, Palo Verde. Half of the electricity that APS supplies to customers comes from clean energy sources, including nuclear.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).